Have you or someone you know been using Zantac on a regular basis to treat heartburn?
You need to be aware of testing conducted by the Food and Drug Administration (FDA) so you can protect your rights.
In September 2019, the FDA found low levels of NDMA (N-nitrosodimethylamine) in Zantac and its generic equivalent, ranitidine. The U.S. Environmental Protection Agency considers NDMA to be a substance capable of causing cancer.
Following the FDA’s findings, a number of drug companies issued a voluntary recall on the drug, and several national pharmacy chains pulled the medication from their shelves.
Millions of Americans use Zantac or ranitidine (both in prescription and over-the-counter forms) on a daily basis as an antacid or to treat other digestive issues.
Are you one of those people?
Have you or someone you know developed some form of cancer?
Goodrich and Associates is actively investigating cases that where someone regularly uses the medication and then has subsequently been diagnosed with cancer.
If someone from a drug company contacts you, please contact us to discuss your case.Back